AVA
TBIO
Atlas Venture Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,872,115
| Closed | -$51.6M | – | 9 |
|
|
2021
Q2 | $51.6M | Hold |
1,872,115
| – | – | 5.35% | 3 |
|
|
2021
Q1 | $30.9M | Sell |
1,872,115
-784,402
| -30% | -$12.9M | 5.7% | 2 |
|
|
2020
Q4 | $49M | Sell |
2,656,517
-1,176,603
| -31% | -$21.7M | 10.98% | 2 |
|
|
2020
Q3 | $52.2M | Sell |
3,833,120
-88,888
| -2% | -$1.21M | 8.78% | 2 |
|
|
2020
Q2 | $70.3M | Hold |
3,922,008
| – | – | 17.93% | 2 |
|
|
2020
Q1 | $39.1M | Hold |
3,922,008
| – | – | 52.94% | 1 |
|
|
2019
Q4 | $31.9M | Hold |
3,922,008
| – | – | 48.23% | 1 |
|
|
2019
Q3 | $38.9M | Hold |
3,922,008
| – | – | 12.06% | 2 |
|
|
2019
Q2 | $49.5M | Hold |
3,922,008
| – | – | 20.5% | 2 |
|
|
2019
Q1 | $40M | Hold |
3,922,008
| – | – | 20.18% | 2 |
|
|
2018
Q4 | $29.4M | Buy |
+3,922,008
| New | +$29.4M | 15.53% | 2 |
|